NCT00880750 - Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 28, 2009

Primary Completion Date

June 22, 2009

Study Completion Date

June 22, 2009

Conditions

End Stage Renal Disease

Interventions

DRUG

Lanthanum carbonate Granule Formulation

3x's per day for 3 days, 1 dose in the am for day 4. (A single dose equals 1000mg of lanthanum carbonate granule formulation. Dose is administered immediately after each meal.)

DRUG

Lanthanum carbonate Chewable Tablets (Fosrenol)

3x's per day for 3 days, 1 dose on day 4. (A single dose equals a 1000mg tablet of lanthanum carbonate. Dose is administered immediately after each meal.)

Trial Locations (1)

90630

West Coast Clinical Trials, LLC, Cypress